OpGen, Inc. provided revenue guidance for the year 2023. The company expects continue pursuing significant revenue growth opportunities, especially with Unyvero product sales and ARESiss services, both in the U.S. and internationally; expect global revenues from products, services and collaborations for 2023 to be in the range of approximately $4 million to $5 million.